Python is one of the most approachable languages to learn, thanks to its object-oriented-first approach and its minimal syntax. The standard library includes many useful modules that you can use to ...

When you're trying to get the best performance out of Python, most developers immediately jump to complex algorithmic fixes, using C extensions, or obsessively running profiling tools. However, one of ...

If last weekend’s crypto crash taught investors anything, it’s not to celebrate too soon. The downturn didn’t stop with the weekend; it rolled straight into the new week. The pullback hit major crypto ...

Strategy (Nasdaq: MSTR), formerly MicroStrategy, reported the financial results for the fourth quarter of 2025 on Feb. 5. The world's largest Bitcoin (BTC) treasury company posted a net loss of $12.4 ...

MicroStrategy (MSTR) fell 62.5% year-over-year despite holding 713,502 bitcoins at 10% above its $76,052 cost basis. MicroStrategy reported a $17.44B unrealized loss in Q4 due to fair value accounting ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

Evernorth holds 388 million XRP tokens purchased at an average price of $2.44, making it the largest institutional XRP holder. The company plans to list on Nasdaq under ticker XRPN in Q1 2026 through ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The Federal Trade Commission and Cigna's Evernorth unit have officially reached a settlement that resolves allegations that the company's pharmacy benefit manager artificially drove up prices for ...

Fri, February 6, 2026 at 4:10 PM UTC After adopting fair value accounting for crypto assets in Q1 2025, MSTR reported a $17.44 billion unrealized loss on digital assets in Q4 2025. This drove EPS to ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...